Travis Murdoch, MD

Travis Murdoch, MD is an experienced professional with a diverse background. Travis is the Founder & CEO of HI-Bio and a Partner at Monograph Capital, both of which they joined in 2021. In 2020, they became a Board Member at Karius, and in 2018, they served as a Board Member at Zymergen. From 2018 to 2022, they held multiple roles at SoftBank Investment Advisers, including Advisor and Director. Additionally, they served as a Board Member at Guardant Health AMEA from 2019 to 2022, and as a Board Observer at Relay Therapeutics from 2019 to 2020. Prior to that, they were a Principal at Third Rock Ventures in 2017. Murdoch also contributed as part of the Founding Team at Ambys Medicines and Rheos Medicines in 2017.

Travis Murdoch, MD holds a Master of Science degree in Integrated Immunology from the University of Oxford, which they completed in 2008. Prior to that, they obtained a Bachelor's degree in Medical Science from the University of Alberta in 2004. Subsequently, they pursued their Doctor's degree in Medicine with Special Training in Research at the University of Alberta, completing it in 2009. Additionally, Travis Murdoch, MD is a Fellow of the Royal College of Physicians of Canada; however, the specific details regarding the institution and the year of obtaining this certification are not provided.